

Minerva Neurosciences develops and commercializes clinical-stage products for the treatment of central nervous system diseases. Among its major competitors, Minerva Neurosciences is ranked in 9th place for NPS while Sage Therapeutics is 1st, and ACADIA Pharmaceuticals is 2nd.